SPIN Study on Mental Health Symptoms in Scleroderma during COVID-19 Published in Lancet Rheumatology
SPIN publishes protocol for the self-management (SPIN-SELF) Program
SPIN Study on Pain in Scleroderma Published in Lancet Rheumatology
SPIN is currently seeking applicants for a full-time Data Manager and Analyst in patient-engaged Health Research and Novel Clinical Trials with the Scleroderma Patient-centered Intervention Network. Please see the job description for more details.
📣 SPIN will soon launch its SPIN-SELF Feasibility Trial to test SPIN’s scleroderma self-management program!
Dr. Brett Thombs, founder and director of SPIN, was recently interviewed by Beth Miller, board member of the Scleroderma Association of British Columbia (SABC) about SPIN’s research projects and our patient-centered interventions.
We are excited to announce that our project “Mental Health in People at Risk from COVID-19 Due to a Pre-Existing Medical Condition: Longitudinal Study of Risk Factors, Outcomes, and the Role of Vaccination” has been awarded a one-year CIHR grant!
SPIN is currently seeking applicants for a Full-time Research Assistant position in patient-engaged health research. Please see the job description for more details.
We are excited to share that Dr. Brett Thombs has just been awarded the Scleroderma Foundation’s 2021 “Messenger of Hope” award.
SPIN is currently seeking applicants for a postdoctoral fellowship position in patient-engaged health research and novel clinical trials. Please see the job description below for more details.
Results from the SPIN - Physical ACtivity Enhancement (SPIN-PACE) in scleroderma Survey was recently accepted for publication in Arthritis Care & Research.
Please note that the SPIN research team cannot access the firstname.lastname@example.org mailbox at the moment. Please email us at email@example.com.
The Canada Research Chairs are awarded to world-class researchers who are recognized internationally as leaders in their fields.
The first study to explore factors associated with fears during COVID-19 in a vulnerable population with a pre-existing medical condition and the first study to apply the validated COVID-19 Fears Questionnaire for Chronic Medical Conditions.
Results from the COVID-19 Fears Questionnaire for Chronic Medical Conditions were recently published in the Journal of Psychosomatic Research.